Q4 2013 13F Holders as of 31 Dec 2013
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
21,007,246
-
Share change
-
+425,843
-
Total reported value
-
$237,590,818
-
Put/Call ratio
-
25%
-
Price per share
-
$11.31
-
Number of holders
-
86
-
Value change
-
+$4,856,177
-
Number of buys
-
3
-
Number of sells
-
2
Institutional Holders of ACELRX PHARMACEUTICALS INC - COM (ACRX) as of Q4 2013
As of 31 Dec 2013 ACELRX PHARMACEUTICALS INC - COM (ACRX) had 86 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 21,007,246 shares of stock of the company.
Largest 10 holders included PERCEPTIVE ADVISORS LLC, Foresite Capital Management I, LLC, WELLS FARGO & COMPANY/MN, BlackRock Fund Advisors, DRIEHAUS CAPITAL MANAGEMENT LLC, GRANAHAN INVESTMENT MANAGEMENT INC/MA, Cormorant Asset Management, LLC, FMR LLC, VANGUARD GROUP INC, and Independence Capital Asset Partners, LLC.
This table shows 86 institutional shareholders of the security as of 31 Dec 2013.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.